Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 2,896
Out of 5,182 analysts
55
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $34.02 | +30.69% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.84 | +313.22% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $85.18 | +11.53% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $36.26 | +98.57% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $114.87 | +26.23% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,262.48 | +2.97% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $300.73 | -5.23% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $178.98 | +38.00% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $166.79 | +64.88% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $259.57 | +4.02% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $9.34 | +199.79% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $16.21 | +115.92% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $470.22 | +10.59% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.29 | +3,023.92% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $117.43 | +57.54% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $158.98 | +38.38% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $102.49 | +114.66% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $7.86 | +256.23% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $195.05 | -28.22% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $53.51 | +68.19% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $34.02
Upside: +30.69%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.84
Upside: +313.22%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $85.18
Upside: +11.53%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $36.26
Upside: +98.57%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $114.87
Upside: +26.23%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,262.48
Upside: +2.97%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $300.73
Upside: -5.23%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $178.98
Upside: +38.00%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $166.79
Upside: +64.88%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $259.57
Upside: +4.02%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $9.34
Upside: +199.79%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $16.21
Upside: +115.92%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $470.22
Upside: +10.59%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.29
Upside: +3,023.92%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $117.43
Upside: +57.54%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $158.98
Upside: +38.38%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $102.49
Upside: +114.66%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $7.86
Upside: +256.23%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $195.05
Upside: -28.22%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $53.51
Upside: +68.19%